Literature DB >> 16115885

Analysis of U1 small nuclear RNA interaction with cyclin H.

William O'Gorman1, Benjamin Thomas, Kon Yew Kwek, Andre Furger, Alexandre Akoulitchev.   

Abstract

TFIIH is a general transcription and repair factor implicated in RNA polymerase II transcription, nucleotide excision repair, and transcription-coupled repair. Genetic defects in TFIIH lead to three distinct inheritable diseases: xeroderma pigmentosa, Cockayne syndrome, and trichothiodystrophy, with xeroderma pigmentosa patients being highly susceptible to skin cancer. Earlier data revealed that the cyclin H subunit of TFIIH associates with U1 small nuclear RNA, a core-splicing component. In addition to its role in RNA processing U1 small nuclear RNA also regulates diverse stages of transcription by RNA polymerase II both in vivo and in vitro, including abortive initiation and re-initiation. Here we identify structural components of U1 and cyclin H implicated in the direct interaction and show how they affect function. Because of unique features of cyclin H we have developed a new methodology for mapping RNA interaction with the full-length cyclin H polypeptide based on electrospray ionization tandem mass spectrometry. We also demonstrate the importance of U1 stem-loops 1 and 2 for the interaction with cyclin H. Functional assays implicate the identified interaction with U1 in regulation of the activity of the cyclin H associated kinase CDK7.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16115885     DOI: 10.1074/jbc.M505791200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Transcription control by long non-coding RNAs.

Authors:  Tyler Faust; Alan Frankel; Iván D'Orso
Journal:  Transcription       Date:  2012-03-01

2.  Detection of protein-RNA crosslinks by NanoLC-ESI-MS/MS using precursor ion scanning and multiple reaction monitoring (MRM) experiments.

Authors:  Christof Lenz; Eva Kühn-Hölsken; Henning Urlaub
Journal:  J Am Soc Mass Spectrom       Date:  2007-03-08       Impact factor: 3.109

Review 3.  TFIIH: when transcription met DNA repair.

Authors:  Emmanuel Compe; Jean-Marc Egly
Journal:  Nat Rev Mol Cell Biol       Date:  2012-05-10       Impact factor: 94.444

Review 4.  Where splicing joins chromatin.

Authors:  Jarmila Hnilicová; David Staněk
Journal:  Nucleus       Date:  2011 May-Jun       Impact factor: 4.197

5.  The non-coding B2 RNA binds to the DNA cleft and active-site region of RNA polymerase II.

Authors:  Steven L Ponicsan; Stephane Houel; William M Old; Natalie G Ahn; James A Goodrich; Jennifer F Kugel
Journal:  J Mol Biol       Date:  2013-02-08       Impact factor: 5.469

6.  RNA-RNA interactions enable specific targeting of noncoding RNAs to nascent Pre-mRNAs and chromatin sites.

Authors:  Jesse M Engreitz; Klara Sirokman; Patrick McDonel; Alexander A Shishkin; Christine Surka; Pamela Russell; Sharon R Grossman; Amy Y Chow; Mitchell Guttman; Eric S Lander
Journal:  Cell       Date:  2014-09-25       Impact factor: 41.582

Review 7.  How Research on Human Progeroid and Antigeroid Syndromes Can Contribute to the Longevity Dividend Initiative.

Authors:  Fuki M Hisama; Junko Oshima; George M Martin
Journal:  Cold Spring Harb Perspect Med       Date:  2016-04-01       Impact factor: 6.915

8.  Tra2β protein is required for tissue-specific splicing of a smooth muscle myosin phosphatase targeting subunit alternative exon.

Authors:  Kang Fu; Ylva Mende; Bhupal P Bhetwal; Salah Baker; Brian A Perrino; Brunhilde Wirth; Steven A Fisher
Journal:  J Biol Chem       Date:  2012-03-21       Impact factor: 5.157

Review 9.  Riboactivators: transcription activation by noncoding RNA.

Authors:  Aseem Z Ansari
Journal:  Crit Rev Biochem Mol Biol       Date:  2009 Jan-Feb       Impact factor: 8.250

10.  Efficient transcription through an intron requires the binding of an Sm-type U1 snRNP with intact stem loop II to the splice donor.

Authors:  Marina R Alexander; Adam K Wheatley; Rob J Center; Damian F J Purcell
Journal:  Nucleic Acids Res       Date:  2010-01-13       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.